Rocket


Overview
Financials
News + Filings





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Pharmagreen Biotech Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Dec-31-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21
   10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K
Revenues  0.00.00.20.00.00.00.00.1
            Revenue growth     -100.0% -100.0%-100.0%2514.6%
Cost of goods sold  0.00.00.00.00.00.10.00.1
Gross profit  0.00.00.20.00.0-0.10.00.0
            Gross margin  34.8%-2.3%100.0%    9.8%
Selling, general and administrative   [+]0.00.00.00.00.00.00.10.0
Research and development          
Other operating expenses  0.00.20.30.20.20.90.10.3
EBIT   [+]-0.1-0.2-0.2-0.2-0.2-1.0-0.2-0.3
            EBIT margin  -11763.0%-19520.5%-98.5%    -196.2%
Interest expense  0.00.00.00.00.00.00.00.0
Other income (expense), net   [+]-0.10.00.20.10.50.00.2-0.6
Pre-tax income  -0.2-0.20.0-0.10.3-1.00.0-0.8
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0% 
Minority interest  0.0  0.0   0.0
Net income  -0.2-0.20.0-0.10.3-1.00.0-0.8
            Net margin  -27287.3%-19520.5%-21.4%    -597.3%
   
Basic EPS   [+]$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Diluted EPS   [+]$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
   
Shares outstanding (basic)   [+]445.1403.7403.7218.7613.5326.0326.0293.7
Shares outstanding (diluted)   [+]445.1403.7403.7403.7613.5326.0326.0326.0
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy